Generic antiepileptic drug equivalence: The journey from anecdotes to evidence

Generic antiepileptic drug (AED) substitution has been a controversial topic for many years. Every day several million tablets of generic AEDs are taken by people with epilepsy. Generic drugs can be an important weapon to combat healthcare costs –the US Food and Drug Administration (FDA) estimated $230 billion per year was saved by generic substitution in all therapeutic categories. However, advocacy groups have criticized widespread generic substitution in people with epilepsy because the FDA rules allow too much variability across diffe rent products.
Source: Epilepsy Research - Category: Neurology Authors: Source Type: research